Thomas H. Tulip

2013

In 2013, Thomas H. Tulip earned a total compensation of $730.9K as President and Chief Business Officer at Navidea Biopharmaceuticals, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$71,094
Option Awards$319,066
Salary$334,750
Other$6,000
Total$730,910

Tulip received $334.8K in salary, accounting for 46% of the total pay in 2013.

Tulip also received $71.1K in non-equity incentive plan, $319.1K in option awards and $6K in other compensation.

Rankings

In 2013, Thomas H. Tulip's compensation ranked 7,932nd out of 12,286 executives tracked by ExecPay. In other words, Tulip earned more than 35.4% of executives.

ClassificationRankingPercentile
All
7,932
out of 12,286
35th
Division
Manufacturing
2,869
out of 4,612
38th
Major group
Chemicals And Allied Products
892
out of 1,462
39th
Industry group
Drugs
675
out of 1,156
42nd
Industry
In Vitro and In Vivo Diagnostic Substances
29
out of 56
48th
Source: SEC filing on June 5, 2015.

Tulip's colleagues

We found four more compensation records of executives who worked with Thomas H. Tulip at Navidea Biopharmaceuticals in 2013.

2013

Mark Pykett

Navidea Biopharmaceuticals

Chief Executive Officer

2013

Cornelia Reininger

Navidea Biopharmaceuticals

Chief Medical Officer

2013

Frederick Cope

Navidea Biopharmaceuticals

Chief Scientific Officer

2013

Brent Larson

Navidea Biopharmaceuticals

Chief Financial Officer

You may also like